Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Pharmaceutical Retailers

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for MEDPLUS
Revenue projections for MEDPLUS

MEDPLUS's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 2.90300
forwardPE 39.13855
debtToEquity 64.68900
earningsGrowth 0.43000
revenueGrowth 0.06500
grossMargins 0.25567
operatingMargins 0.04781
trailingEps 16.28000
forwardEps 19.81167

MEDPLUS's current ratio of 2.903 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. MEDPLUS's ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
MedPlus Health Services Limited's forward EPS is higher than its trailing EPS, suggesting the company is expected to see an increase in profitability this year. This points to positive growth, indicating that MedPlus Health Services Limited is projected to improve its financial performance compared to the previous year.

Price projections:

Price projections for MEDPLUS
Price projections for MEDPLUS

The current price of MEDPLUS, relative to its projections, shows no clear risks or opportunities. This neutral assessment may encourage investors to take a cautious approach, awaiting further developments before making substantial changes.

Recommendation changes over time:

Recommendations trend for MEDPLUS
Recommendations trend for MEDPLUS


A recent buy bias from analysts toward MEDPLUS may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that MEDPLUS might be an appealing option for those looking to grow their wealth through stock market investments.